Time to hit pause on mitochondria-targeting cancer therapies.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 36658424.
- Also identified by DOI 10.1038/s41591-022-02129-y and PMC identifier 11892798.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As another clinical trial of a mitochondria-targeting cancer therapy faces failure, it calls for a thorough re-evaluation of the strategy; the time has come to go from the bedside back to the bench.
Medical subject headings
- Mitochondria
- Neoplasms